Infection Progression
Infection Progression - Related Videos
05:53
Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
0 Views •
Cited by 6 •
2013
Human Cytomegalovirus (HCMV) infection of neonates represents an important cause of mental retardation, yet the molecular events leading to virus-induced pathogenesis are still poorly understood. To investigate the dynamics of brain infection, we adapted whole-animal in vivo imaging to perform time-course analysis of neonates infected with a luciferase-recombinant virus.
07:59
Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis
0 Views •
Cited by 3 •
2016
This manuscript describes the use of a bioluminescent strain of African trypanosomes to enable the tracking of late stage infection and demonstrates how in vivo live imaging can be used to visualize infections within the central nervous system in real-time.
08:11
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
0 Views •
Cited by 21 •
2016
An optimized testing protocol is presented in this paper for the Rotarod performance test, used for measuring progressive neurological disability in TMEV-infected mice.
02:07
Tumor Progression
0 Views •
2023
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages. Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07
Tumor Progression
0 Views •
2021
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages. Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
FAQs
Pathogen replication can increase the burden of infectious material within the host and alter how extensively tissues are involved. As replication changes over time, the clinical picture may shift from an early infection toward worsening disease or, if host defenses gain control, recovery. Monitoring this relationship helps clinicians interpret whether the process is advancing or responding to intervention.
The tissues reached by a pathogen influence which parts of the host are affected and how the infection develops. Routes of transmission within the body help explain movement from an initial site to additional tissues. Considering both factors gives clinicians a more complete view of progression and supports assessment of possible complications rather than focusing only on the first affected location.
Host susceptibility affects how effectively the body responds after exposure, while inflammation reflects part of the interaction between immune defenses and the pathogen. A strong inflammatory response may contribute to clinical deterioration even as the immune system acts against infection. Evaluating susceptibility and inflammation together helps explain why similar infectious processes can produce different outcomes in different patients.
Clinical tracking compares changes over time rather than relying on a single point in the illness. Patterns consistent with increasing pathogen activity, broader tissue involvement, or a stronger inflammatory response may indicate worsening disease. Conversely, stabilization or improvement can support recovery. This time-based assessment also helps identify complications and guides decisions about whether the current management remains appropriate.
Clinicians follow the sequence of changes in pathogen replication, tissue involvement, host susceptibility, and inflammatory response. They use this evolving picture to distinguish early infection, progression, recovery, and complications. The purpose is not simply to label an infection, but to recognize meaningful changes over time that can support timely diagnosis and more informed clinical decisions.
Recognizing the stage and direction of change helps clinicians select or adjust treatment in relation to the patient’s condition. The same assessment can inform infection-control planning by clarifying how the pathogen is moving through the host and how the situation is evolving. Tracking outcomes afterward also helps evaluate whether care is associated with recovery or whether complications are emerging.